Archives: Speakers

Work

1996-2006 – Unilever, Varying roles across Sales and Marketing

2006-2010 – General Manager Rosslyn Park F.C. (Rugby Union)

2010-2015 – Unilever, Asda followed by Out of Home Ice Cream Channel and Strategy Controller (Walls and Ben & Jerry’s)

2015 to Present – Managing Director Cawston Press

Loves

Rugby, ice cream and apples!

Family

Happily married with 3 children

Hobbies

– Sport (any)

– Spending time with family and friends

– Long walks or cycle rides in the countryside

– Experimenting in the garden

Meredith Frank-Molnia is currently employed as Vice President of Clinical Affairs at Vericel Corporation. Previously, Meredith held the position of Senior Director Clinical Management, while working at Axiom Real-Time Metrics Inc., where she established and expanded their Clinical Management department. Meredith has been in Clinical Project Management/Operations for 26 years in numerous roles of increasing responsibilities. Meredith has worked managing device/biologic and drug studies.

Maria Florez is involved in research looking at the impact of digital transformation in clinical research and organizational strategies and practices driving improvement in development operations and economics. Maria has been a researcher and strategist in the healthcare sector for 15 years. She has held positions at Cleveland Clinic and at New York-Presbyterian Hospital of Columbia and Cornell Universities and has published articles in trade and peer-reviewed journals. She holds a B.S. in economics and an M.A. in international economics from The Fletcher School of Law and Diplomacy at Tufts University.

Research Assistant Professor at Tufts University School of Medicine and Director of Sponsored Projects at Tufts CSDD.
Expertise in benchmarking drug development operating practices.
Research focus includes outsourcing and partnerships; clinical supplies; investigative site initiation and management; patient recruitment and retention; and the use of technologies and digital solutions in clinical trials.
Published extensively and is a frequent speaker at global conferences.
Current Initiatives Include:
• Study volunteer diversity in clinical trials
• Benchmarking patient recruitment and retention practices
• Industry use of automation, IT technologies and applications

Customer-focused healthcare manager with 20+ years of experience (11 years at Takeda/Shire, 7 years at Pfizer/Wyeth) in Clinical Research and Pharmaceutical industries. Expertise managing teams (up to 6 employees); overseeing complex vendor relationships; and negotiating clinical vendor and investigator contracts, and phase I–IV master service agreements. Proven record implementing innovative tools, processes, metrics, strategic practices, and global trainings to improve supplier and site management, outsourcing management, vendor qualification, vendor accountability, contract negotiations, compliance, and profitability. Earned numerous awards for exceeding goals and work excellence.

Dedicated to supporting rare disease patients and caregivers through creating innovative partnerships which allow patients to access resources easily. Demonstrated history of working in the Consumer Product Goods industry. Skilled in Brand Partnerships, Relationship Building, Account Management, Sales, Marketing, and Team Building. Master’s Degree focused in Business Administration and Integrated Communications from Suffolk University – Sawyer Business School.

George Tetz, MD, PhD, and CEO/Cofounder of Second Life Group, has dedicated his life’s work to addressing some of medicine’s most unmet needs.

Second Life Group includes three different clinical-stage entities, including Second Life Therapeutics, Second Life Diagnostics, and Second Life Vaccines. Together, these companies address some of the most critical, unmet needs in medicine, including advanced solid tumors, antibiotic resistance and longevity with first-in-class personalized medicines and medical devices.

Throughout his career as both a medical practitioner and researcher, Dr. Tetz has focused on applying cutting-edge multifactorial approaches to a variety of medical problems. One of his most groundbreaking findings is the existence of the previously unknown Universal Receptive System and Teazeled receptors. With this discovery, Dr. Tetz is modulating cellular memory for the first time, bringing cell control to a new and unprecedented level.

Dr. Tetz began his career as a medical practitioner, then earned his PhD in molecular microbiology. He serves as Director of the Department of Systems Biology at the Human Microbiology Institute, where he played an integral role in groundbreaking studies. Dr. Tetz is also a member of the American Society for Microbiology, Society for Neurosciences, and New York Academy of Sciences.